S&P 500
7,588.60
+0.51%
Dow Jones
52,758.90
+0.47%
Nasdaq 100
29,885.70
+0.46%
Russell 2000
2,982.51
-0.27%
FTSE 100
10,543.60
+0.61%
Nikkei 225
69,317.20
+0.42%

Investing

Wednesday’s Top Biotech & Medical Stocks

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

by H.S. Ayoub
BioHealth Investor.com

Biotechnology

CYPRESS BIOSCIENCE [CYPB] +93.73%
CRITICAL THERAPEUTIC [CRTX] +13.43%
REXAHN PHARMACEUTICL [RXHN.OB] +10.00%
NEOSE TECH INC [NTEC] +9.02%
AURIGA LABORATORIES [ARGA.OB] +7.62%

Diagnostic Substances

ASPENBIO PHARMA INC [APNB.OB] +6.24%
AVALON PHARMACEUTIC [AVRX] +4.33%
PALATIN TECH INC [PTN] +4.02%
IMMUNOMEDICS INC [IMMU] +2.47%
SYNTA PHARMACEUTICAL [SNTA] +2.45%

Drug Delivery

NOVADEL PHARMA INC [NVD] +9.40%
INSITE VISION INC [ISV] +4.90%
BENTLEY PHARMACEUTIC [BNT] +4.45%
NEKTAR THERAPEUTIC [NKTR] +2.34%
PENWEST PHARM CO [PPCO] +0.48%

Drug Manufacturers

CARRINGTON LABS IN [CARN] +9.66%
DEPOMED INC [DEPO] +4.99%
COLLAGENEX PHARM I [CGPI] +4.89%
JAVELIN PHARMACEUTIC [JAV] +3.86%
ACUSPHERE INC [ACUS] +3.68%

Drug Related Products

MEDICAL NUTRITN USA [MDNU] +7.38%
NUTRACEUTICAL INTL [NUTR] +5.95%
XELR8 HOLDINGS, INC [BZI] +3.60%
SALIX PHARM DEL [SLXP] +3.55%
AUXILIUM PHARMACEUT [AUXL] +3.33%

Generic Drugs

ISOLAGEN INC [ILE] +3.95%
MYLAN LABS INC [MYL] +1.15%
HI-TECH PHARMACAL [HITK] +0.58%
CATALYST PHARMACEUTI [CPRX] +0.49%
PHARMACUTICAL CO [PRX] +0.28%

Medical Appliances & Equipment

MEDICALCV INC [MCVI.OB] +19.17%
VISION SCIENCES IN [VSCI] +12.07%
THERMAGE, INC. [THRM] +8.42%
ATS MEDICAL INC [ATSI] +7.01%
CHAD THERAPEUTICS [CTU] +5.50%

Medical Instruments & Supplies

MESA LABS INC [MLAB] +22.59%
SENORX, INC. [SENO] +13.50%
HEMOSENSE INC. [HEM] +6.55%
ATRICURE, INC. [ATRC] +4.41%
SONOSITE INC [SONO] +4.00%

Medical Laboratories & Research

NATL DENTEX CP [NADX] +5.29% $104.5 M
BIO-IMAGING TECH [BITI] +2.07% $33.5 M
OSI PHARMACEUTIC [OSIP] +0.74% $2.0 B
QUEST DIAGNOSTC [DGX] +0.62% $10.8 B
LABORATORY CORP NEW [LH] +0.57%

Contact [email protected] for any questions or corrections.

Disclaimer: Energy Exploration Technologies, Inc. ("EnergyX") has engaged 24/7 Wall St to publish this communication in connection with EnergyX's ongoing Regulation A offering. 24/7 Wall St has been paid in cash and may receive additional compensation. 24/7 Wall St and/or its affiliates do not currently hold securities of EnergyX.

This compensation and any current or future ownership interest could create a conflict of interest. Please consider this disclosure alongside EnergyX's offering materials. EnergyX's Regulation A offering has been qualified by the SEC. Offers and sales may be made only by means of the qualified offering circular. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at invest.energyx.com/.

Comparisons to other companies are for informational purposes only and should not imply similar results. Past performance is not indicative of future results. Market shortfall are forward‑looking estimates and are subject to substantial uncertainty. Investments in private placements, and start-up investments in particular, are long-term, illiquid, speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups

Follow 24/7 Wall St. on Google
Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Medicare Won't Touch Long-Term Care. The Average Nursing-Home Year Runs Past $100,000.
Drew Wood |

Medicare Won't Touch Long-Term Care. The Average Nursing-Home Year Runs Past $100,000.
Could You Retire Better in Portugal or Costa Rica With $500,000?
Drew Wood |

Could You Retire Better in Portugal or Costa Rica With $500,000?

Continue Reading

Douglas A. McIntyre |

Tuesday’s Top Biotech & Medical Stocks

From BioHealth Investor Biotechnology POLYDEX PHARM LTD [POLXF] +28.84% CERAGENIX PHARMACUTL [CGXP.OB] +9.00% PANACOS PHARMA INC [PANC] +7.76% PIPEX PHARMACEUTICAL…

Douglas A. McIntyre |

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology DYAX CORP [DYAX] +9.51% FERMAVIR PHARMACEUTL [FMVR.OB] +8.57% ZIOPHARM ONCOLOGY IN [ZIOP] +7.30% ALNYLAM PHARMACEUT [ALNY]…

Douglas A. McIntyre |

Tuesday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com Contact [email protected] for any questions or corrections.

Douglas A. McIntyre |

Monday’s Top Biotech & Medical Stocks

From BioHealth Investor Biotechnology CYPRESS BIOSCIENCE [CYPB] +5.81% SGX PHARMACEUTICALS [SGXP] +5.44% AFFYMAX, INC. [AFFY] +5.35% CERAGENIX PHARMACUTL [CGXP.OB] +5.26%…

Douglas A. McIntyre |

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology BIONOVO INC [BNVI.OB] +27.33% $0 CORCEPT THERAPEUTICS [CORT] +20.19% $99.2 M OPEXA THERAPEUTICS [OPXA] +11.11% $0…

Douglas A. McIntyre |

Thursday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com Biotechnology GENETIC TECH SPON [GENE] +48.22% DENDREON CORP [DNDN] +19.69% CORCEPT THERAPEUTICS [CORT] +15.70% ANTIGENICS INC…

Douglas A. McIntyre |

Monday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology BIOSANTE PHARMA INC [BPA] +24.60% REPROS THERAPEUTICS [RPRX] +11.83% SUNESIS PHARMACEUTIC [SNSS] +11.72% POINT THERAPEUTICS [POTP]…

Douglas A. McIntyre |

Thursday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology PIPEX PHARMACEUTICAL [PPXP.OB] +21.70% BIODELIVERY SCI INTL [BDSI] +21.37% AURIGA LABORATORIES [ARGA.OB] +20.83% BIONOVO INC [BNVI.OB]…

Douglas A. McIntyre |

Friday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology VANDA PHARMACEUTICAL [VNDA] +10.30% EMERGENT BIOSOLUTION [EBS] +9.20% BOSTON LIFE SCIENCES [BLSI] +8.03% LEV PHARMACEUTICALS [LEVP.OB]…

Top Gaining Stocks

Meta
META • Vol: 40,760,422
CarMax
KMX • Vol: 2,288,021
Weyerhaeuser
WY • Vol: 6,523,553
SBA Communications
SBAC • Vol: 1,443,801
NVIDIA
NVDA • Vol: 148,249,982

Top Losing Stocks

Moderna
MRNA • Vol: 9,176,778
Coterra Energy
CTRA • Vol: 73,319,495
CrowdStrike
CRWD • Vol: 9,269,567
Datadog
DDOG • Vol: 5,135,556
EPAM Systems
EPAM • Vol: 1,164,561